Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Are These Four Tech Stocks Poised to Explode?

Page 1 of 2

Green investors tend to think that cheap stocks are real bargains, believing that stocks with the lowest prices have the highest potential to generate exorbitant returns. This line of thought is completely wrong, as each stock simply represents a share in the ownership of a company. Each stock is like a piece of a pie and each pie can be cut into many combinations of equal pieces, be it ten pieces or a million. Seasoned investors on the other hand define a cheap stock as a stock that has a relatively low price-to-earnings ratio. Nonetheless, we decided to compile a list of four low-priced technology stocks, which might not necessarily be cheap in terms of valuation. As a retired trader, I can state that most small-scale intra-day traders tend to look for stocks that trade in the range of $10-to-$100 per share, believing that stocks priced under $10 are highly-risky and unsafe. Thus, it is possible to find overlooked gems among stocks whose shares are trading on the cheap. For that reason, we decided to discuss four tech stocks under $10 that managed to capture the attention of a considerable number of investors that we follow.

Sunedison Inc. (NYSE:SUNE)

 – Investors with Long Positions (as of September 30): 73

 – Aggregate Value of Investors’ Holdings (as of September 30): $1.06 Billion

Sunedison Inc. (NYSE:SUNE) is losing its charm among the hedge funds tracked by Insider Monkey, as the number of smart money investors with positions in the company dropped to 73 from 93 during the third quarter. Most importantly, the value of their investments in the company declined to $1.06 billion from the $5.68 billion figure it stood at on June 30. The global renewable energy development company has a capital-intensive business, a substantial amount of indebtedness that totaled $11.67 billion on September 30, and capital needs in the range of $6.5 billion-to-$8.8 billion for financing the development and construction of renewable energy systems through December 31, 2016. The company’s strategy has solely relied on the sale of certain renewable energy systems to its yieldcos, but the disappointing stock performance of those yieldco subsidiaries has increased the cost of capital to finance SunEdison’s growth strategy. Let’s not forget to mention that the shares of SunEdison are 78% in the red so far this year, and some believe that the company’s ongoing liquidity concerns will push the stock even lower. David Einhorn’s Greenlight Capital cut its exposure to Sunedison Inc. (NYSE:SUNE) by 26% during the third quarter to 18.61 million shares.

Follow Sunedison Inc. (NYSE:SUNEQ)
Trade (NYSE:SUNEQ) Now!

Hedge funds have been underperforming the market for a very long time. However, this was mainly because of the huge fees that hedge funds charge as well as the poor performance of their short books. Hedge funds’ long positions actually performed better than the market. Small-cap stocks, activist targets, and spin-offs were among the bright spots in hedge funds’ portfolios. For instance, the 15 most popular small-cap stocks among hedge funds outperformed the market by more than 53 percentage points since the end of August 2012, returning 102% (read the details here). This strategy also managed to beat the market by double digits annually in our back tests covering the 1999-2012 period.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!